Abstract
Background: Osteoporosis is an exceedingly common, morbid, and potentially fatal disease. Efforts to improve the prevention, diagnosis and treatment of osteoporosis in people living in Central Pennsylvania were instituted in 1996 by the Geisinger Health System. With a catchment of over 2 million people, over 600 physicians and 50 primary care sites, this physician-led system of healthcare is uniquely positioned to influence the delivery of healthcare.
Objective: To determine whether the pilot Community Pharmacist Osteoporosis Education Program, a specific project of the osteoporosis disease management program by the Geisinger Health System, improved bone health behavior.
Methods: The Community Pharmacist Osteoporosis Education Program, focused on physician and allied healthcare provider guidelines, community intervention, bone density testing, and outcomes analysis, can improve bone health. A group of highly motivated community-based pharmacists were educated about menopause and osteoporosis prevention, diagnosis, and treatment. They were provided with a uniform educational program and held classes in the community. Baseline, satisfaction, and follow-up questionnaires were administered. High risk participants received a follow-up telephone encounter. Primary care physicians were notified about the program and their patients’ participation.
Results: Approximately 350 women attended the classes. The mean age was 54 years, 99.4% were Caucasian, and 47% had some education beyond high school. One-third had a family history of osteoporosis or fracture. Participants were uniformly satisfied with the course content and class delivery: 74% rated the class as ‘excellent’, 26% as ‘good’. Follow-up questionnaires at 4 to 6 months demonstrated that of those who were not previously doing so, 58% began taking calcium supplements, 32% exercised more, 50% sought the counsel of their primary care physician, 29% obtained a test of bone density, and 33% started a prescription medication for osteoporosis therapy as a result of attending the class. High risk participants were more likely to obtain a test of bone density after the program than were low risk participants.
Conclusion: This program demonstrates that community-based pharmacists can serve as a valuable member of the healthcare provider team. An organized program that provides a standard and consistent educational approach, physician communication, and a reminder system led to better bone health behavior in women in the community.
Similar content being viewed by others
References
Ross PD. Osteoporosis: frequency, consequences, and risk factors. Arch Intern Med 1996; 156: 1399–411
Lindsay R, Christiansen C, Einhorn TA, et al. Consensus development statement: who are candidates for prevention and treatment for osteoporosis? Osteoporosis Int 1997; 7: 1–6
National Osteoporosis Foundation. 1996 and 2015 osteoporosis prevalence figures — state by state report. Washington, DC: National Osteoporosis Foundation, 1997 Jan: 1–11
Newman ED, Starkey RS, Ayoub WT, et al. Osteoporosis disease management: best practices from the Penn State Geisinger Health System. J Clin Outcomes Manage 2000 May; 7(5): 23–8
Newman ED, Ayoub W, Hanus P, et al. Osteoporosis clinical practice guideline. 2nd ed. Danville (PA): Geisinger Health System, 2000 Apr: 1–24
Lydick E, Cook K, Turpin J, et al. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care 1998; 4: 37–48
European Foundation for Osteoporosis and the National Osteoporosis Foundation. Consensus development statement. Who are candidates for prevention and treatment for osteoporosis? Osteoporosis Int 1997; 7: 1–6
American Association of Health Plans. Health plans’innovative programs in mid-life women’s health issues: advancing women’s health. Washington, DC: American Association of Health Plans, 1998
American Society of Health-System Pharmacists. ASHP statement on the pharmacist’s role in primary care. Am J Health Syst Pharm 1999 Aug; 56: 1665–7
Holdford D, Kennedy DT, Bernadella P, et al. Implementing disease management in community pharmacy practice. Clin Ther 1998 Mar–Apr; 20(2): 328–39
Baran RW, Crumlish K, Patterson H, et al. Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling. Am J Health Syst Pharm 1999 Aug; 56: 1535–9
Liu MY, Jennings JP, Samuelson WM, et al. Asthma patients’ satisfaction with the frequency and content of pharmacy counseling. J Am Pharm Assoc 1999 Jul–Aug; 39(4): 493–8
Woolf AD, Delmas PD. How can we reduce the burden of osteoporosis? Bailliere’s Clin Rheumatol 1997 Aug; 11(3): 451–7
Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial. J Clin Endocrinol Metab 2000; 85(11): 4118–24
Miller P, Roux C, McClung M, et al. Risedronate reduces hip fracture in patients with low femoral neck bone mineral density. Arthritis Rheum 1999 Sep; 9 Suppl.: S287
O’Neill T, Papapoulos S. Can we prevent fractures? Bailliere’s Clin Rheumatol 1997 Aug; 11(3): 565–82
Acknowledgements
We acknowledge the Wilkes University School of Pharmacy for their support of the pharmacist educational training, Merck & Co., Inc. for their assistance in program design, and Design-a-Care Advisory Group for their assistance in facilitating program implementation. This program was supported in part by unrestricted educational grants from Merck & Co., Inc., Wyeth-Ayerst Laboratories, and Novartis Pharmaceuticals.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Newman, E.D., Hanus, P. Improved Bone Health Behavior Using Community Pharmacists as Educators. Dis-Manage-Health-Outcomes 9, 329–335 (2001). https://doi.org/10.2165/00115677-200109060-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00115677-200109060-00004